Literature DB >> 24766157

Management of IRVAN syndrome with observation.

Madhi Basha, Gary C Brown, Geremie Palombaro, Carol L Shields, Jerry A Shields.   

Abstract

A 7-year-old girl with IRVAN (idiopathic retinal vasculitis, aneurysms, and neuroretinitis) syndrome was monitored for 9 years. The patient had symmetric multiple aneurysmal dilations, retinal vasculitis, and severe hard exudation in the macula bilaterally. Long-term visual acuity in her untreated right eye was 20/25. In the left eye, treated with laser panretinal photocoagulation and intravitreal vascular endothelial growth factor inhibitor therapy, visual acuity decreased to 20/200 from macular hard exudates and central fibrovascular tissue. Observation is a consideration in IRVAN syndrome if the vision remains good with hard exudation. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24766157     DOI: 10.3928/23258160-20140331-02

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  4 in total

1.  [Atypical retinal vasculitis].

Authors:  A William; C Rössler; C Binder
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

2.  Idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN): case series of three patients with multimodal imaging.

Authors:  Yu Jeat Chong; Abison Logeswaran; Ambreen Sarmad; Erika Marie Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-15       Impact factor: 3.117

3.  Single Bilateral Dexamethasone Implant in Addition to Panretinal Photocoagulation and Oral Azathioprine Treatment in IRVAN Syndrome.

Authors:  Ali Osman Saatci; Ziya Ayhan; Ömer Takeş; Aylin Yaman; F Meltem Söylev Bajin
Journal:  Case Rep Ophthalmol       Date:  2015-02-11

Review 4.  Comprehensive overview of IRVAN syndrome: a structured review of Case Reports and Case Series.

Authors:  Hashim Ali Khan; Qaim Ali Khan; Muhammad Aamir Shahzad; Muhammad Amer Awan; Naeemullah Khan; Smaha Jahangir; Fiza Shaheen; Kamran Wali; Julie Rodman; Jozeph Pizzimenti; Ali Osman Saatci
Journal:  Ther Adv Ophthalmol       Date:  2022-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.